Erectile preservation following radical prostatectomy
- 1 February 2011
- journal article
- Published by SAGE Publications in Therapeutic Advances in Urology
- Vol. 3 (1) , 35-46
Abstract
Prostate cancer is the most common cancer among men, representing approximately 25% of all new cancer diagnoses in the USA. For clinically localized prostate cancer, the gold standard for therapy remains radical prostatectomy. One of the main adverse effects of this procedure is erectile dysfunction, which can have a significant impact on the patient’s quality of life. There are several mechanisms of erectile dysfunction postprostatectomy, including arteriogenic, venogenic and neurogenic types, as well as the potentially heightened risk of postprostatectomy patients to develop Peyronie’s disease. The purpose of this review is to explain the various treatment options available, including phosphodiesterase type 5 inhibitors, intracavernosal injections, intraurethral alprostadil suppositories, vacuum erection devices, and penile prostheses. The role of these therapies in an erectile-dysfunction-treatment function, as well as in penile rehabilitation, will be discussed. Finally, a review of research on novel therapies will also be presented. A comprehensive literature review was performed using the PubMed database. Articles were chosen based on topical relevance and assessed for methodology and major findings. There are data to support the use of each of the therapeutic options in both treatment and rehabilitative roles. More study is needed, however, specifically in regard to penile rehabilitation, to confirm its benefits, as well as to determine optimal rehabilitation protocols.Keywords
This publication has 72 references indexed in Scilit:
- Gene therapy as future treatment of erectile dysfunctionExpert Opinion on Biological Therapy, 2010
- Comparative Effectiveness of Prostate Cancer Surgical Treatments: A Population Based Analysis of Postoperative OutcomesJournal of Urology, 2010
- Increased cyclic guanosine monophosphate production and endothelial nitric oxide synthase level in mononuclear cells from sildenafil citrate-treated patients with erectile dysfunctionInternational Journal Of Impotence Research, 2009
- Radical Prostatectomy Versus Watchful Waiting in Localized Prostate Cancer: the Scandinavian Prostate Cancer Group-4 Randomized TrialJNCI: Journal of the National Cancer Institute, 2008
- Herpes simplex virus vector-mediated delivery of neurturin rescues erectile dysfunction of cavernous nerve injuryGene Therapy, 2008
- Acceptance of and Discontinuation Rate from Erectile Dysfunction Oral Treatment in Patients following Bilateral Nerve-Sparing Radical ProstatectomyEuropean Urology, 2008
- A pilot study on the early use of the vacuum erection device after radical retropubic prostatectomyBJU International, 2007
- Herpes simplex virus vector-mediated delivery of glial cell line-derived neurotrophic factor rescues erectile dysfunction following cavernous nerve injuryGene Therapy, 2007
- Combination Therapy: Medicated Urethral System for Erection Enhances Sexual Satisfaction in Sildenafil Citrate Failure Following Nerve‐Sparing Radical ProstatectomyJournal of Andrology, 2005
- Treatment of Men with Erectile Dysfunction with Transurethral AlprostadilNew England Journal of Medicine, 1997